Hoffnagle J H, Gerety R J, Barker L F
Am J Med Sci. 1975 Jul-Aug;270(1):179-87. doi: 10.1097/00000441-197507000-00025.
Two distinct antigen-antibody systems are associated with the hepatitis B virus (HBV): hepatitis B surface antigen (HBs Ag) and antibody (anti-HBs) and the more recently described hepatitis B core antigen (HBc Ag) and antibody (anti-HBc). Testing of serial serum samples from patients with type B hepatitis demonstrates the regular occurrence of anti-HBc during the course of this disease. In general, highest titers of anti-HBc are seen with prolonged circulation of HBs Ag as in the chronic carrier state. Titers of anti-HBc begin to fall with recovery from HBV infection and anti-HBc appears to be shorter lived than anti-HBs. As such, anti-HBc testing is important in documenting the occurrence of infection with HBV and is of great value in epidemiologic studies and in evaluating the safety and efficacy of hepatitis B immune globulin and HBV vaccines.
两种不同的抗原 - 抗体系统与乙型肝炎病毒(HBV)相关:乙型肝炎表面抗原(HBs Ag)和抗体(抗 - HBs),以及最近描述的乙型肝炎核心抗原(HBc Ag)和抗体(抗 - HBc)。对B型肝炎患者的系列血清样本进行检测表明,在这种疾病过程中抗 - HBc会经常出现。一般来说,在慢性携带者状态下,随着HBs Ag的长期循环,抗 - HBc的滴度最高。抗 - HBc的滴度随着HBV感染的恢复而开始下降,并且抗 - HBc的存在时间似乎比抗 - HBs短。因此,抗 - HBc检测对于记录HBV感染的发生很重要,在流行病学研究以及评估乙型肝炎免疫球蛋白和HBV疫苗的安全性和有效性方面具有重要价值。